Lin LW, Lin XY, He YM, Gao SD, Lin XD. Biological characteristics of HCC by ultrasound-guided aspiration biopsy and its clinical application. World J Gastroenterol 2003; 9(5): 941-945
Corresponding Author of This Article
Li-Wu Lin, Ultrasound Department, Union Hospital of Fujian Medical University, Fuzhou 350001, Fujian Province, China. email@example.com
Article-Type of This Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. May 15, 2003; 9(5): 941-945 Published online May 15, 2003. doi: 10.3748/wjg.v9.i5.941
Biological characteristics of HCC by ultrasound-guided aspiration biopsy and its clinical application
Li-Wu Lin, Xue-Ying Lin, Yi-Mi He, Shang-Da Gao, Xiao-Dong Lin
Li-Wu Lin, Xue-Ying Lin, Yi-Mi He, Shang-Da Gao, Xiao-Dong Lin, Fujian Provincial Ultrasonic Medicine Institute, Ultrasound Department, Union Hospital of Fujian Medical University, Fuzhou 350001, Fujian Province, China
ORCID number: $[AuthorORCIDs]
Author contributions: All authors contributed equally to the work.
Correspondence to: Li-Wu Lin, Ultrasound Department, Union Hospital of Fujian Medical University, Fuzhou 350001, Fujian Province, China. firstname.lastname@example.org
Received: November 19, 2002 Revised: November 27, 2002 Accepted: January 2, 2003 Published online: May 15, 2003
AIM: To probe the pathological biological characteristics of hepatocellular carcinoma (HCC) by the ultrasound-guided aspiration biopsy and assess the clinical application value of this method.
METHODS: The biopsy and DNA analysis by flow cytometry (FCM) were taken in 46 cases with HCC nodules, including 26 cases and 20 cases with nodules ≤ 3 cm and > 3 cm in diameters respectively, and 12 cases with intrahepatic benign hyperplastic nodules. They were taken in 22 cases of 46 cases with HCC before and after the therapy. Fine-needles and automatic histological incised biopsy needles were used. The fresh biopsy tissue was produced into the single cell suspension, which was sent for DNA detection and ratio analysis of cell period. The ratio of each DNA period of cell proliferation of each group was calculated and compared with each other. The DNA aneuploid (AN) and apoptosis cell peak were observed and their percentages were calculated.
RESULTS: The ratios of S and G2/M periods of DNA, which reflect cell hyperproliferation, in the group with HCC tumors > 3 cm in diameter were markedly higher than those of the group with HCC nodules ≤ 3 cm in diameter and the group with the benign hyperplastic nodules (P < 0.01 except A:B of S period, P < 0.05). The ratios of the middle group were also apparently higher than those of the latter group (P < 0.01). The ratio of DNA AN of 46 cases with HCC nodules was 34.8% (16/46). None of the cases with the intrahepatic hyperplastic nodules appeared AN. The DNA AN appeared more apparently with the growth of the tumors. The AN ratio of the group with tumors > 3 cm in diameter was 55% (11/20), markedly higher than that of the group with tumors ≤ 3 cm in diameter which was 19.2% (5/26) (P < 0.01). The FCM DNA analysis of 22 specimens of hepatic carcinoma tissue before therapy showed that the aneuploid peaks appeared in 5 cases (22.7%). The ratio of G1 period rose after therapy while the S period and G2/M ratios fell (P < 0.01). The aneuploid peak disappeared in the 5 cases after the therapy, while the apoptosis peaks in 12 cases (54.5%) appeared.
CONCLUSION: Addition to supply the information of the pathological morphology of the tumor, the ultrasound-guided fine-needle aspiration tissue could be sent for FCM DNA analysis to comprehend its pathological biological characteristics. This can not only provide the clinic the reliable information about the occurrence, development, diagnosis, curative effect and prognosis of tumors but also supply biological information for clinic to choose therapeutic schemes.
Key Words: $[Keywords]
Citation: Lin LW, Lin XY, He YM, Gao SD, Lin XD. Biological characteristics of HCC by ultrasound-guided aspiration biopsy and its clinical application. World J Gastroenterol 2003; 9(5): 941-945
Recently, with the wide use of flow cytometry (FCM) in clinic, it becomes possible to make pathological diagnosis develop from qualitative analysis of the morphology to quantitative analysis[1-5]. The study of DNA analysis of the biological characteristics of hepatocellular carcinoma (HCC) model and hepatectomy specimens of man HCC has greatly developed[6-18]. But the study of DNA analysis of the pathological biological characteristics of HCC specimens acquired from the ultrasound-guided aspiration biopsy has been rarely reported[15,19]. In our study, the ultrasound-guided aspiration biopsy and the FCM DNA analysis were taken in 46 cases with HCC, including 22 cases with HCC before and after the therapy and 12 cases with intrahepatic benign hyperplastic nodules (IBHN) in order to probe the biological characteristics of HCC and assessed the clinical application value of this research.
MATERIALS AND METHODS
Forty-six cases with HCC, including 26 cases and 20 cases with nodules 3 cm and > 3 cm in diameters respectively, consisted of 39 males and 7 females. The mean age was 53.7 years (range, 29-72). Twenty-two of 46 cases taking ultrasound-guided interventional therapy included 16 males and 6 females. Twelve cases with IBHN comprised 7 males and 5 females and the average age was 47.5 years (range, 27-58). The diagnosis was established by cytopathological and/or histological examinations.
Instruments and methods
The apparatuses were Aloka-650 and 1700 with 3.5-MHz probe. All cases took aspiration biopsy with 22G PTC needles. Twenty-two cases with HCC took percutaneous ethanol or other anti-tumor drug injection therapy for 5-8 times after biopsy, then took aspiration biopsy once again. The 18G automatic histological incised biopsy needle (producted by C.R. Bard, Inc, American) was used if the specimen taken by the fine needle aspiration was unsatisfactory. The amount of platelet of the patient must be > 60 × 109/L and the mobility of thrombogen of the cases must be > 50%. The process of fine-needle aspiration biopsy was as follows. The point of puncture in the skin was determined by ultrasonography. Then sterilization, drape and local paralysis were done. The fine needle punctured through the point into the focus. The needle was twitched up and down in the focus. At the same time, the negative pressure was kept in the syringe. The needle was taken out when the tissue and/or tissue with blood were seen in the syringe. The aspirated material was divided into three parts. One part was smeared on glass slides for pathological examination. The second part was placed in 10% formalin or electron microscope (EM) liquid for electron microscopy. The last part was placed in 10 ml physiological saline for cytometric DNA analysis. The process of puncture of automatic histological incised biopsy was similar to that of fine-needle aspiration biopsy. The needle punctured to the periphery of the mass, ejected and excised the tumor tissue, then was extracted quickly. The sample was 19.0 mm in length and 1.0 mm in diameter.
The examination method of FCM
The FACScan (B.D. company, America) was adopted. At first, the fresh biopsy tissue was produced into the single cell suspension. Then it was stained by PI for DNA analysis. DNA content was measured and the ratio of each DNA period of cell proliferation was analyzed. The ratio of each DNA period, the percentage of the DNA aneuploid (AN) and the percentage of apoptosis cell peak were observed.
The average value and standard deviation of the percentage of the ratio of cell proliferation and DNA AN stem-line of each group were calculated respectively. The student-t test or student-t’ test was used to test whether the mean of each group was different from each other. A difference was regarded as significance if P < 0.05.
Table 1 showed the ratio of each DNA period of cell proliferation of each group. Statistical analysis showed that the ratio of S and G2/M periods of DNA, which reflect cell hyperproliferation, in the group with HCC tumors > 3 cm in diameter were markedly higher than those of the group with nodules ≤ 3 cm in diameter and the group with the benign hyperplastic nodules (P < 0.01 except A:B of S period, P < 0.05). The ratios of the middle group were also apparently higher than those of the latter group (P < 0.01). The apparent characteristics were that the DNA of IBHN was steadily in G1 period, which means the nonproliferation diploid (2c) state (Figure 1). While the DNA of HCC cell stayed in unstable division stage and appeared the cell hyperproliferation state (Figure 2) with the development of foci.
Table 1 The ratios of cell proliferation of HCC in different diameter and benign hyperplastic nodules (%, -x±s).
Characteristics of foci
Number of cases
DNA analysis of each period
The group with HCC > 3 cm (A)
40.3 ± 6.8
43.5 ± 7.4
16.2 ± 1.7
The group with HCC ≤ 3 cm(B)
57.7 ± 5.8
30.4 ± 5.2
11.9 ± 1.1
The group with IBHN (C)
94.8 ± 0.7
2.6 ± 0.5
2.6 ± 0.4
G1 period A:B A:C B:C P < 0.01; S period A:B P < 0.05, S period B: C A:C P < 0.01; G2/M period A:B B:C A:C P < 0.01.
Figure 1 DNA analysis of aspiration biospy tissues acquired from intrahepatic benign hyperplastic nodules showed steady diploid (2C) peak that stayed in G1 period (single red peak).
Figure 2 DNA analysis of aspiration biopsy tissues acquired from HCC nodules showed S period of hyperproliferation (the peak with oblique lines) and G2/M period (the second red peak).
The statistical materials also showed that the ratio of DNA AN stem-line of 46 cases with HCC nodules was 34.8%(16/46) (Figure 3). While none of cases with IBHN appeared AN stem-line. The DNA appeared AN more apparently with the growth of the tumors. The AN ratio of the group with tumors > 3 cm in diameter was 55% (11/20), markedly higher than that of the group with tumors ≤ 3 cm in diameter which was 19.20% (5/26) (P < 0.01).
Figure 3 DNA analysis of HCC nodules showed aneuploid (AN) peak (the orange peak).
The pathological results of 22 cases among 46 cases with HCC after the ultrasound-guided percutaneous interventional therapy showed that the tumor cells appeared pyknosis and necrosis in various degrees. The Table 2 showed the results of FCM DNA analysis of the aspiration tissue. The ratio of G1 period which reflects cell steady state rose apparently after therapy (P < 0.01). While the ratios of S period and G2/M period which reflect cell hyperproliferation fell (P < 0.01). After therapy the AN peaks disappeared in 5 cases which appeared before therapy and the apoptosis peaks appeared in 12 cases (54.5%) (Figure 4) which was consistent with the cell pyknosis and dark nuclear staining showed by the histopathologic examination and the typical apoptosis cell or/and apoptosis body showed by the electron microscopy (Figure 5).
Table 2 Cell proliferative ratios of 22 cases with HCC before and after ultrasound-guided interventional therapy (%, -x± s).
Time of detect
Each period of cell proliferation (%)
52.6 ± 7.2
37.5 ± 8.1
9.9 ± 1.9
94.7 ± 4.1
3.7 ± 2.5
1.6 ± 0.5
a: b of each period P < 0.01.
Figure 4 DNA a na lysis of HCC nodules showed hyperproliferation state before therapy (left) and apoptosis peak after therapy (the blue peak).
Figure 5 The same cases as those in figure.
4 appeared typical apoptosis cells and apoptosis bodies after therapy.
The application value of cytopathological and histological examinations using ultrasound-guided aspiration biopsy has been affirmed in clinic[20-22]. There are also many scholars using many immunological methods to study the biological characteristics of hepatic tumors[23-45]. But the study of DNA detection of intrahepatic tumor tissue by ultrasound-guided fine-needle aspiration or incising biopsy[15,19] is rarely reported. On the basis of comparative study between ultrasound-guided fine-needle and heavy-needle biopsy, we made pathomophological examination of HCC nodules that were different in diameter, HCC nodules before and after therapy as well as benign hyperplastic nodules by ultrasound-guided puncturing biopsy. At the same time[46-48], the fresh biopsy tissue was produced into the single cell suspension which was sent for FCM DNA detection and ratio analysis of cell period. The changing process of cell proliferation was observed. Through the study of biological characteristics of hepatic carcinoma and pathological comparison of hepatic carcinoma tissue before and after the therapy, we probed the application value of DNA analysis in assessment of the therapeutic efficacy and prognosis.
It is determined by the biological behavior of the cell itself that the normal tissue, reactive tissue and benign tumor all have normal diploid DNA. Like most other malignant tumors, HCC appears polyploid DNA, especially AN DNA. AN has become a reliable cytobiological signs of human malignant tumors. On the other side, like other malignant tumors, the occurrence and development pattern of HCC also relate to a biological behavior that changes from a relative steady benign state in the early period to a high proliferative malignant state[3,4,7,11]. The study of HCC model of animal shows that, acted by the carcinogen the animal based on the hepatic cirrhosis appears the proliferation group of new born hepatocytes with diploid DNA stem-line which has highly proliferative activity and the potential ability of malignant tendency. That is the cytological basis of carcinogenesis later. The continuous changes of DNA stem-line in the process of occurrence and development of HCC form the characteristics of the various biological dynamic mechanism from early relative benign state to markedly malignant state of high proliferation. The course of DNA stem-line changing from 2C to AN is an important pathobiological sign. So the study of biological characteristics of HCC has the important clinical practical value for early diagnosis, selection of therapeutic schemes and judgment of prognosis of HCC. In our study, DNA analysis of HCC tissue by ultrasound-guided puncturing aspiration biopsy was made before and after therapy. The ratio of each period in cell period showed that the ratios of synthesis phase (S period) and mitosis phase (G2/M period) which reflect high proliferation of HCC group were apparently higher than those of benign hyperplastic group (P < 0.01) and that the ratios of S and G2/M period apparently rose with the growth of the tumors. As we all know, DNA, as the material basis of heredity of biotic bodies, is mainly located in chromosome of nucleus. The degree of maturation is closely relative to DNA content. The cell in non-proliferative state is characterized by 2C DNA stem-line. The DNA content increases multiply when cells enter division stage and DNA changes into AN stem-line. With the increasing of malignant degree of cell, the structure and amount of chromosome are more abnormal and the phenomena of changing into high proliferative state and AN is more remarkable. On the basis of the studies of animal HCC model and hepatectomic human HCC sample, Cong MW regards that the smaller HCC < 3 cm in diameter is mainly characterized by diploid DNA stem-line which indicates relatively slow growth, lower malignant degree, tumors mostly having capsules, foci limiting, lower distant metastasis rate and lower occurring rates of thrombosis and satellite foci of tumor[3,4]. All these are the pathological basis of conducting radical operation. Our material also shows that 34.8% of 46 cases with HCC appeared AN. The ratio of AN of the group with tumor > 3 cm in diameter reached 55.0% (11/20), markedly higher than that of the group with tumor ≤ 3 cm in diameter which was 19.2% (5/26) (P < 0.01). None of the cases with IBHN appeared AN. It is worth mentioning that, with the growth of tumor, the DNA gradually changes from low proliferation to AN stem-line at certain extent, which reflects that pathobiological characteristics is in relation to the size of tumor nodules. But it is not consistent thoroughly. In our study, the diameter of a small HCC nodule was only 1.1 cm, yet the DNA analysis characterized it by typical AN stem-line (Figure 3).
Many scholars have made the researches in the relationship between the ploidy type and the prognosis of many tumors including HCC by FCM DNA analysis[50-54]. But the study of DNA analysis by ultrasound-guided fine-needle biopsy to assess the therapeutic efficacy has been rarely reported. In our study, DNA analysis of tumor biopsy tissue shows that the AN stem-line which appeared before therapy disappeared after the ultrasound-guided interventional therapy with the cancer cell being killed. The ratios of S and G2/M periods all fell obviously (P < 0.01) and 54.5% cases appeared physiological death process which was different from common necrosis, in another word, appeared apoptosis peak before G0-G1 period. All these changes were consistent with what had been seen in pathological examination. DNA content rose multiply and the cell appeared polyploid when the cell entered division stage. In pathological state, especially for cancer cells, the structure and amount of chromosome became abnormal and the phenomenon of polyploid and/or AN became more remarkable. Summarily, the content and periods of DNA decreased and increased with dying and recurring of the cancer cell[2,5,56]. The materials also show that DNA analysis could supply reliable biological information and objective quantification index.
This study shows that besides providing pathomorphological information of cytology and histology, the tissues acquired by ultrasound-guided puncturing biopsy could also be sent for FCM DNA analysis to comprehend the biological characteristics of tumors. So this method attains the objective of "one needle, three uses" and provides valuable clinical basis for diagnosis, therapeutic efficacy and prognosis assessment of tumors and is worth further studying.
Edited by Ren SY
Qi J, Zhang YC. Using flow cytometry to proccess DNA analysis and several problems of this method.Baiqiuen Yike Daxue Xuebao. 1993;19:516-517.
Chen MF, Hwang TL, Tsao KC, Sun CF, Chen TJ. Flow cytometric DNA analysis of hepatocellular carcinoma: preliminary report.Surgery. 1991;109:455-458.
Nagasue N, Yamanoi A, Takemoto Y, Kimoto T, Uchida M, Chang YC, Taniura H, Kohno H, Nakamura T. Comparison between diploid and aneuploid hepatocellular carcinomas: a flow cytometric study.Br J Surg. 1992;79:667-670.
Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T, Fujimoto J, Oriyama T, Furukawa K, Kawamura E. Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis.Cancer. 1990;65:1104-1110.
Coon JS, Landay AL, Weinstein RS. Flow cytometric analysis of paraffin-embedded tumors: implications for diagnostic pathology.Hum Pathol. 1986;17:435-437.
Cong WM, Wu MC, Zhang XZ. Characteristic changes of DNA stemlines during hepatocarcinogenesis in rats.Chin Med J (Engl). 1992;105:535-538.
Cong WM, Wu MC, Chen H. Development of diagnosis and therapy in hepatocellular carcinoma.Zhongguo Shiyong Waike Zazhi. 1997;17:3-4.
Lu DD. The DNA analysis of hepatocarcinoma.Yixue Tongxun Zazhi. 1999;28:21-24.
Cheng HH, Zheng ZY, Gao Z, Yang RY, Yu YH. The clinical value of the detect of DNA content and cell proliferative activity of primary hepatocellular carcinoma.Zhongguo Zhongliu Linchuang Yu Kangfu. 1996;3:25-26.
Cong WM, Wu MC. The biopathologic characteristics of DNA content of hepatocellular carcinomas.Cancer. 1990;66:498-501.
Fujimoto J, Okamoto E, Yamanaka N, Toyosaka A, Mitsunobu M. Flow cytometric DNA analysis of hepatocellular carcinoma.Cancer. 1991;67:939-944.
Ruà S, Comino A, Fruttero A, Torchio P, Bouzari H, Taraglio S, Torchio B, Capussotti L. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.Cancer. 1996;78:1195-1202.
Wen XF, Ma ZC, Lin ZY, Ye QH, Tang ZQ. The clinical value of DNA content in the recurrence of hepatocellular carcinoma-Logistic model.Zhongguo Puwai Jichu Yu Linchuang Zazhi. 2001;8:236-238.
Shi GJ, Hu YL, Zhao YR. The relationship of DNA content and morphometric data of nuclear feature in primany hepatocellular carcinoma and clinical value.Gandan Waike Zazhi. 1997;5:233-235.
Anti M, Marra G, Rapaccini GL, Rumi C, Bussa S, Fadda G, Vecchio FM, Valenti A, Percesepe A, Pompili M. DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy.Cancer. 1994;73:281-288.
Joensuu H, Klemi PJ. Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma.Am J Clin Pathol. 1988;89:35-40.
Wersto RP, Liblit RL, Koss LG. Flow cytometric DNA analysis of human solid tumors: a review of the interpretation of DNA histograms.Hum Pathol. 1991;22:1085-1098.
Ezaki T, Kanematsu T, Okamura T, Sonoda T, Sugimachi K. DNA analysis of hepatocellular carcinoma and clinicopathologic implications.Cancer. 1988;61:106-109.
Cottier M, Jouffre C, Maubon I, Sabido O, Barthelemy C, Cuilleron M, Veyret C, Laurent JL, Audigier JC. Prospective flow cytometric DNA analysis of hepatocellular carcinoma specimens collected by ultrasound-guided fine needle aspiration.Cancer. 1994;74:599-605.
Chen YL, Chen F, Hu ZQ, Wang HP. Study on technological improvement by ultrasound-guided percutaneous renal biopsy.Zhonghua Chaosheng Yingxiangxue Zazhi. 2000;9:234-236.
Tang J, Li S, Xu JH, Yang YY, Li JL, Luo YK, Dong BW. Evalua-tion of biopsy guided by ultrasound in the diagnosis of prostatic intraepithelial neoplasia.Zhonghua Chaosheng Yingxiangxue Zazhi. 2000;9:465-468.
Dong BW, Liang P, Yu XL, Su L, Yu DJ, Zhang J. The clinical usefulness of color Doppler ultrasonography-guided percutaneous biopsy for pancreatic masses.Zhonghua Chaosheng Yingxiangxue Zazhi. 2001;10:219-221.
Deng ZL, Ma Y. Aflatoxin sufferer and p53 gene mutation in hepatocellular carcinoma.World J Gastroenterol. 1998;4:28-29.
Sun JJ, Zhou XD, Liu YK, Zhou G. Phase tissue intercellular adhesion molecule-1 expression in nude mice human liver cancer metastasis model.World J Gastroenterol. 1998;4:314-316.
Yang SM, Zhou H, Chen RC, Wang YF, Chen F, Zhang CG, Zhen Y, Yan JH, Su JH. Sequencing of p53 mutation in established human hepatocellular carcinoma cell line of HHC4 and HHC15 in nude mice.World J Gastroenterol. 1998;4:506-510.
Zhang LF, Peng WW, Yao JL, Tang YH. Immunohistochemical detection of HCV infection in patients with hepatocellular carcinoma and other liver diseases.World J Gastroenterol. 1998;4:64-65.
Luo D, Liu QF, Gove C, Naomov N, Su JJ, Williams R. Analysis of N-ras gene mutation and p53 gene expression in human hepatocellular carcinomas.World J Gastroenterol. 1998;4:97-99.
Jiang SM, Xu ZH. Serum deprivation enhances DNA synthesis of human hepatoma SMMC7721 cells.World J Gastroenterol. 1998;4:121-124.
Peng XM, Peng WW, Yao JL. Codon 249 mutations of p53 gene in development of hepatocellular carcinoma.World J Gastroenterol. 1998;4:125-127.
Sun JJ, Zhou XD, Zhou G, Liu YK. Expression of intercellular adhesive molecule-1 in liver cancer tissues andliver cancer metastasis.World J Gastroenterol. 1998;4:202-205.
Huang B, Wu ZB, Ruan YB. Expression of nm23 gene in hepatocellular carcinoma tissue and its relation with metastasis.World J Gastroenterol. 1998;4:266-267.
Liu Y, Zhang BH, Qian GX, Chen H, Wu MC. Detection of blood AFPmRNA in nude mice bearing human HCC using nested RT-PCR and its significance.World J Gastroenterol. 1998;4:268-270.
Zheng N, Ye SL, Sun RX, Zhao Y, Tang ZY. Effects of cryopreservation and phenylacetate on biological characters of adherent LAK cells from patients with hepatocellular carcinoma.World J Gastroenterol. 2002;8:233-236.
Liu LX, Jiang HC, Liu ZH, Zhou J, Zhang WH, Zhu AL, Wang XQ, Wu M. Integrin gene expression profiles of human hepatocellular carcinoma.World J Gastroenterol. 2002;8:631-637.
Wang X, Liu FK, Li X, Li JS, Xu GX. Inhibitory effect of endostatin expressed by human liver carcinoma SMMC7721 on endothelial cell proliferation in vitro.World J Gastroenterol. 2002;8:253-257.
Sun ZJ, Pan CE, Liu HS, Wang GJ. Anti-hepatoma activity of resveratrol in vitro.World J Gastroenterol. 2002;8:79-81.
Tian G, Yu JP, Luo HS, Yu BP, Yue H, Li JY, Mei Q. Effect of nimesulide on proliferation and apoptosis of human hepatoma SMMC-7721 cells.World J Gastroenterol. 2002;8:483-487.
Liu H, Wang Y, Zhou Q, Gui SY, Li X. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.World J Gastroenterol. 2002;8:480-482.
Wang FS, Liu MX, Zhang B, Shi M, Lei ZY, Sun WB, Du QY, Chen JM. Antitumor activities of human autologous cytokine induced killer (CIK) cells against hepatocellular carcinoma cells in vito and in vivo.World J Gastroenterol. 2002;8:464-468.
Qin LX, Tang ZY, Ma ZC, Wu ZQ, Zhou XD, Ye QH, Ji Y, Huang LW, Jia HL, Sun HC. P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.World J Gastroenterol. 2002;8:459-463.
Huang GW, Yang LY. Metallothionein expression in hepatocellular carcinoma.World J Gastroenterol. 2002;8:650-653.
Feng DY, Chen RX, Peng Y, Zheng H, Yan YH. Effect of HCV NS(3) protein on p53 protein expression in hep atocarcinogenesis.World J Gastroenterol. 1999;5:45-46.
He P, Tang ZY, Ye SL, Liu BB. Relationship between expression of alpha-fetoprotein messenger RNA and some clinical parameters of human hepatocellular carcinoma.World J Gastroenterol. 1999;5:111-115.
Lee JH, Ku JL, Park YJ, Lee KU, Kim WH, Park JG. Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA.World J Gastroenterol. 1999;5:289-295.
Martins C, Kedda MA, Kew MC. Characterization of six tumor suppressor genes and microsatellite instability in hepatocellular carcinoma in southern African blacks.World J Gastroenterol. 1999;5:470-476.
Lin LW, He YM, Gao SD, Yang FD, Ye Z, Xue ES, Yu LY, Lin XD. Value of ultrasound-guided fine-needle aspiration biopsy and ejection heavy needle biopsy in deagnosis and assessment of therapeutic effect for hepatic carcinona.Zhonghua Chaosheng Yingxiangxue Zazhi. 2001;10:608-610.
Zhang W, Lv GR, Jia JW, Ran WQ, Miao LY, Shi XD, Huang MW, Zhao R, Ding LH, Feng LZ. Clinical applications of automatic biopsy technique under the guidance of ultrasound.Zhonghua Chaosheng Yingxiangxue Zazhi. 1993;2:38-41.
Dong BW, Liang P, Yu XL, Su L, Yu DJ, Zhang J. Comparison of clinical usefulness of US-guided core (18G) and fine (21G) needles biopsy analysis.Zhonghua Chaosheng Yingxiangxue Zazhi. 2000;9:71-73.
Zhang YH. The use of flow cytometry in laboratory medical.Zhonghua Yixue Jianyan Zazhi. 1997;20:203-205.
Liu L, Zhang C. [DNA ploidy analysis and Ki-67 examination on renal neoplasms: investigation of degree of malignancy and biological behavior of small renal tumors].Zhonghua Binglixue Zazhi. 2001;30:39-42.
Rugge M, Sonego F, Sessa F, Leandro G, Capella C, Sperti C, Pasquali C, Di Mario F, Pedrazzoli S, Ninfo V. Nuclear DNA content and pathology in radically treated pancreatic carcinoma. The prognostic significance of DNA ploidy, histology and nuclear grade.Cancer. 1996;77:459-466.
Southern JF, Warshaw AL, Lewandrowski KB. DNA ploidy analysis of mucinous cystic tumors of the pancreas. Correlation of aneuploidy with malignancy and poor prognosis.Cancer. 1996;77:58-62.
Huang T, Yu EX, Cao SL. Relationship between DNA ploidy and prognosis in hepatocellular carcinoma after radiation therapy.Zhongguo Aizheng Zazhi. 1999;9:203-205.
Qin XL, Jia HL, Tang ZQ. The characteristics and prognosis of hepatic carcinoma.Zhongliu. 2001;21:473-476.
Lin LW, He YM, Gao SD, Yu LY, Ye Z, Xue ES, Lin XD. Value of DNA analsis of ultrasound-guided fine-needle aspiration biopsy in assessment of therapeutic efficacy for hepatic carcinoma.Zhonghua Chaosheng Yingxiangxue Zazhi. 2001;10:538-541.
Peng LM. Development of the study of cytoapoptosis detect.Zhonghua Yixue Jianyan Zazhi. 1996;19:336-338.